Hemopexin: A Novel Anti-inflammatory Marker for Distinguishing COPD From Asthma

PURPOSE: Systemic inflammatory biomarkers can improve diagnosis and assessment of chronic obstructive pulmonary disease (COPD) and asthma. We aimed to validate an airway disease biomarker panel of 4 systemic inflammatory biomarkers, α2-macroglobulin, ceruloplasmin, haptoglobin and hemopexin, to esta...

Descripción completa

Detalles Bibliográficos
Autores principales: Winter, Natasha A., Gibson, Peter G., Fricker, Michael, Simpson, Jodie L., Wark, Peter A., McDonald, Vanessa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984952/
https://www.ncbi.nlm.nih.gov/pubmed/33733639
http://dx.doi.org/10.4168/aair.2021.13.3.450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984952/
https://www.ncbi.nlm.nih.gov/pubmed/33733639
http://dx.doi.org/10.4168/aair.2021.13.3.450

Ejemplares similares